Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond

American Journal of Kidney Diseases

Volumn 34, Issue 1, 1999, Pages 173-176

  Mittman, N ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; EDITORIAL; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; LONG TERM CARE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE;

EID: 0033048937     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70127-7     Document Type: Editorial

References (39)

1. JW Eschbach MR Downing JC Egrie JK Browne JW Adamson USA multicenter clinical trial with recombinant human erythropoietin Contrib Nephrol 76 1989 160 165
2. JW Eschbach The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin Kidney Int 35 1989 134 148
3. JW Eschbach JC Egrie MR Downing JK Browne JW Adamson Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of the phase I and phase II clinical trial N Engl J Med 316 1987 73 78
4. JW Adamson JW Eschbach Management of the anemia of chronic renal failure with recombinant erythropoietin Q J Med 272 1989 1093 1101
5. DA Ogden Monitoring considerations in recombinant human erythropoietin therapy Semin Nephrol 9 1989 S12 S15 (suppl 2)
6. G Sunder-Plassmann WH Horl Importance of iron supply for erythropoietin therapy Nephrol Dial Transplant 10 1995 2070 2076
7. IC Macdougall Poor response to erythropoietin: Practical guidelines on investigation and management Nephrol Dial Transplant 10 1995 607 614
8. S Fishbane JK Maesaka Iron management in end-stage renal disease Am J Kidney Dis 29 1997 319 333
9. RL Wingard RA Parker N Ismail RM Hakim Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin Am J Kidney Dis 25 1995 433 439
10. IC Macdougall B Tucker J Thompson CRV Tomson LRI Baker AEG Raine A randomized controlled study of iron supplementation in patients treated with erythropoietin Kidney Int 50 1996 1694 1699
11. NKF-DOQI Clinical Practice Guidelines for the treatment of anemia of chronic renal failure Am J Kidney Dis 30 1997 S192 S240 (suppl 3)
12. S Fishbane RI Lynn The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients Clin Nephrol 44 1995 238 240
13. AR Nissenson RM Lindsay S Swan P Seligman J Strobos Serum ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial Am J Kidney Dis 33 1999 471 482
14. S Fishbane G Frei J Maesaka Reduction in recombinant human erythropoietin dose by the use of chronic intravenous iron supplementation Am J Kidney Dis 26 1995 41 46
15. A Besarab JW Kaiser S Frinak A study of parenteral iron regimens in hemodialysis patients Am J Kidney Dis 34 1999 21 28
16. AL Zanen HJ Andriaansen EFH van Bommel R Posthuma GM de Jong ‘Oversaturation’ of transferrin after intravenous ferric gluconate in haemodialysis patients Nephrol Dial Transplant 11 1996 820 824
17. I MacDougall Strategies for iron supplementation: Oral versus intravenous Kidney Int 55 1999 S61 S66 (suppl 69)
18. S Fishbane Iron treatment: Impact of safety issues Am J Kidney Dis 32 1998 S152 S156 (suppl 4)
19. R Raja E Bloom M Goldstein R Johnson Erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients: A comparison in an inner city population ASAIO J 39 1993 M578 M580
20. SW Zimmerman CA Johnson Erythropoietin use in peritoneal dialysis patients Am J Kidney Dis 18 1991 S38 S41 (suppl 1)
21. SF Lui CB Law SM Ting P Li KN Lai Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Clin Nephrol 36 1991 246 251
22. V Jonnalagadda EJ Bloom RM Raja Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis Adv Perit Dial 13 1997 113 115
23. P Barany N Clyne B Hylander AC Johansson O Simonsen R Larsson C Frisenette-Fich B Svensson C Helmers Subcutaneous epoetin beta in renal anemia: An open multicenter dose titration study of patients on continuous peritoneal dialysis Perit Dial Int 15 1995 54 60
24. AR Nissenson S Korbet M Faber J Burkart D Gentile R Hamburger W Mattern M Schreiber R Swartz J Van Stone A Watson S Zimmerman Multicenter trial of erythropoietin in patients on peritoneal dialysis J Am Soc Nephrol 5 1995 1517 1529
25. F Akcicek M Ozkahya M Cirit E Ok A Unsal H Toz A Celik G Atabay A Basci The efficiency of fractionated parenteral iron treatment in CAPD patients Adv Perit Dial 13 1997 109 112
26. M Auerbach J Winchester A Wahab K Richards M McGinley F Hall J Anderson G Briefel A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients Am J Kidney Dis 31 1998 81 86
27. N Ahsan Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: A single center comparative study J Am Soc Nephrol 9 1998 664 668
28. DF Bainton CA Finch The diagnosis of iron deficiency anemia Am J Med 37 1964 62 70
29. CA Finch Erythropoiesis, erythropoietin and iron Blood 60 1982 1241 1246
30. P Pootrakul K Kitcharoen P Yansukon The effect of erythroid hyperplasia on iron balance Blood 71 1988 1124 1129
31. C Brugnara LA Chambers E Malynn MA Goldberg MS Kruskall Red cell regeneration induced by subcutaneous recombinant human erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects Blood 81 1993 956 964
32. RM Schaefer L Schaefer The hypochromic red cell: A new parameter for monitoring of iron supplementation during rHuEPO therapy J Perinat Med 23 1995 83 88
33. VF Fairbanks E Beutler Iron deficiency ed 5 Williams Hemaotology 1995 McGraw Hill New York, NY 490 511
34. E Beutler The red cell indices in the diagnosis of iron-deficiency anemia Ann Intern Med 50 1959 313
35. IC Macdougall I Cavill B Hulme B Bain E MacGregor P McKay E Sanders GA Coles JD Williams Detection of functional iron deficiency during erythropoietin treatment: A new approach Br Med J 304 1992 225 226
36. C Brugnara GM Colella J Cremins RC Langley TJ Schneider CJ Rutherford MA Goldberg Effects of subcutaneous recombinant human erythropoietin in normal subjects: Development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis J Lab Clin Med 123 1994 660 667
37. S Fishbane C Galgano RC Langley W Canfield JK Maesaka Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients Kidney Int 52 1997 217 222
38. N Mittman R Sreedhara R Mushnick J Chattopadhyay D Zelmanovic M Veseghi MM Avram Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO Am J Kidney Dis 30 1997 912 922
39. S Domrongkitchaiporn B Jirakranont K Atamasrikul A Ungkanont A Bunyaratvej Indices of iron status in continuous ambulatory peritoneal dialysis patients Am J Kidney Dis 34 1999 29 35